Correlation Between I Mab and Ascendis Pharma
Can any of the company-specific risk be diversified away by investing in both I Mab and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining I Mab and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between I Mab and Ascendis Pharma AS, you can compare the effects of market volatilities on I Mab and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in I Mab with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of I Mab and Ascendis Pharma.
Diversification Opportunities for I Mab and Ascendis Pharma
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between IMAB and Ascendis is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding I Mab and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and I Mab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on I Mab are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of I Mab i.e., I Mab and Ascendis Pharma go up and down completely randomly.
Pair Corralation between I Mab and Ascendis Pharma
Given the investment horizon of 90 days I Mab is expected to under-perform the Ascendis Pharma. In addition to that, I Mab is 1.53 times more volatile than Ascendis Pharma AS. It trades about -0.45 of its total potential returns per unit of risk. Ascendis Pharma AS is currently generating about 0.01 per unit of volatility. If you would invest 12,769 in Ascendis Pharma AS on August 24, 2024 and sell it today you would earn a total of 1.00 from holding Ascendis Pharma AS or generate 0.01% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
I Mab vs. Ascendis Pharma AS
Performance |
| Timeline |
| I Mab |
| Ascendis Pharma AS |
I Mab and Ascendis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with I Mab and Ascendis Pharma
The main advantage of trading using opposite I Mab and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if I Mab position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.The idea behind I Mab and Ascendis Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Ascendis Pharma vs. Lyra Therapeutics | Ascendis Pharma vs. Hookipa Pharma | Ascendis Pharma vs. Cingulate Warrants | Ascendis Pharma vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |